Identification of cepharanthine as an effective inhibitor of African swine fever virus replication
African swine fever virus (ASFV) causes highly contagious swine disease, African swine fever (ASF), thereby posing a severe socioeconomic threat to the global pig industry and underscoring that effective antiviral therapies are urgently required. To identify safe and efficient anti-ASFV compounds, a...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Taylor & Francis Group
2024-12-01
|
| シリーズ: | Emerging Microbes and Infections |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2429624 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
| _version_ | 1839627617732395008 |
|---|---|
| author | Chuanxiang Qi Jiyoung Lee Yongqiang Zhang Huan Chen Jiaxuan Lv Zhenzhong Wang Jinming Li Xiaodong Wu Yong-Sam Jung Zhiliang Wang Yingjuan Qian |
| author_facet | Chuanxiang Qi Jiyoung Lee Yongqiang Zhang Huan Chen Jiaxuan Lv Zhenzhong Wang Jinming Li Xiaodong Wu Yong-Sam Jung Zhiliang Wang Yingjuan Qian |
| author_sort | Chuanxiang Qi |
| collection | DOAJ |
| description | African swine fever virus (ASFV) causes highly contagious swine disease, African swine fever (ASF), thereby posing a severe socioeconomic threat to the global pig industry and underscoring that effective antiviral therapies are urgently required. To identify safe and efficient anti-ASFV compounds, a natural compound library was screened by performing an established cell-based ELISA in an ASFV-infected porcine alveolar macrophage (PAM) model. In total, 6 effective anti-ASFV compounds with low cytotoxicity were identified. Cepharanthine (CEP), a bisbenzylisoquinoline alkaloid, was the most potent inhibitor effect with an IC50 of 0.3223 μM. To further investigate the mechanism through which CEP inhibits ASFV replication, transcriptome profiles were generated in PAMs treated with CEP and/or infected with ASFV. ASFV infection dramatically altered immune response-associated gene expression. CEP treatment upregulated the expression of cholesterol biosynthesis-related genes, regardless of infection status. According to time-of-addition experiments, CEP primarily exerts its antiviral effect during the early stages of ASFV infection, specifically by inhibiting viral entry. Transcriptomic analysis suggested that CEP blocks ASFV entry through the clathrin-mediated endocytosis pathway by increasing EHD2 gene expression in macrophages. Disrupting EHD2 with small interfering RNA promoted ASFV entry into clathrin-positive vesicles. Finally, the protective effect of CEP in vivo was evaluated using ASFV-infected pigs. CEP could provide partial protection against ASFV infection, as indicated by an increase in survival time from 9.67 days to 16.67 days. Our findings imply that CEP exhibits potential antiviral activity against ASFV infection in PAMs, positioning it as a promising therapeutic strategy for ASF. |
| format | Article |
| id | doaj-art-e793e2098fac4fbe9f7f453dfabe66bf |
| institution | Matheson Library |
| issn | 2222-1751 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Emerging Microbes and Infections |
| spelling | doaj-art-e793e2098fac4fbe9f7f453dfabe66bf2025-07-16T07:22:48ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512024-12-0113110.1080/22221751.2024.2429624Identification of cepharanthine as an effective inhibitor of African swine fever virus replicationChuanxiang Qi0Jiyoung Lee1Yongqiang Zhang2Huan Chen3Jiaxuan Lv4Zhenzhong Wang5Jinming Li6Xiaodong Wu7Yong-Sam Jung8Zhiliang Wang9Yingjuan Qian10One Health Laboratory, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People’s Republic of ChinaOne Health Laboratory, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People’s Republic of ChinaChina Animal Health and Epidemiology Center, Qingdao, People’s Republic of ChinaOne Health Laboratory, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People’s Republic of ChinaOne Health Laboratory, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People’s Republic of ChinaOne Health Laboratory, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People’s Republic of ChinaChina Animal Health and Epidemiology Center, Qingdao, People’s Republic of ChinaChina Animal Health and Epidemiology Center, Qingdao, People’s Republic of ChinaOne Health Laboratory, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People’s Republic of ChinaChina Animal Health and Epidemiology Center, Qingdao, People’s Republic of ChinaOne Health Laboratory, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, People’s Republic of ChinaAfrican swine fever virus (ASFV) causes highly contagious swine disease, African swine fever (ASF), thereby posing a severe socioeconomic threat to the global pig industry and underscoring that effective antiviral therapies are urgently required. To identify safe and efficient anti-ASFV compounds, a natural compound library was screened by performing an established cell-based ELISA in an ASFV-infected porcine alveolar macrophage (PAM) model. In total, 6 effective anti-ASFV compounds with low cytotoxicity were identified. Cepharanthine (CEP), a bisbenzylisoquinoline alkaloid, was the most potent inhibitor effect with an IC50 of 0.3223 μM. To further investigate the mechanism through which CEP inhibits ASFV replication, transcriptome profiles were generated in PAMs treated with CEP and/or infected with ASFV. ASFV infection dramatically altered immune response-associated gene expression. CEP treatment upregulated the expression of cholesterol biosynthesis-related genes, regardless of infection status. According to time-of-addition experiments, CEP primarily exerts its antiviral effect during the early stages of ASFV infection, specifically by inhibiting viral entry. Transcriptomic analysis suggested that CEP blocks ASFV entry through the clathrin-mediated endocytosis pathway by increasing EHD2 gene expression in macrophages. Disrupting EHD2 with small interfering RNA promoted ASFV entry into clathrin-positive vesicles. Finally, the protective effect of CEP in vivo was evaluated using ASFV-infected pigs. CEP could provide partial protection against ASFV infection, as indicated by an increase in survival time from 9.67 days to 16.67 days. Our findings imply that CEP exhibits potential antiviral activity against ASFV infection in PAMs, positioning it as a promising therapeutic strategy for ASF.https://www.tandfonline.com/doi/10.1080/22221751.2024.2429624African swine fever viruscepharanthinecholesterol biosynthesistranscriptome analysisEHD2 |
| spellingShingle | Chuanxiang Qi Jiyoung Lee Yongqiang Zhang Huan Chen Jiaxuan Lv Zhenzhong Wang Jinming Li Xiaodong Wu Yong-Sam Jung Zhiliang Wang Yingjuan Qian Identification of cepharanthine as an effective inhibitor of African swine fever virus replication Emerging Microbes and Infections African swine fever virus cepharanthine cholesterol biosynthesis transcriptome analysis EHD2 |
| title | Identification of cepharanthine as an effective inhibitor of African swine fever virus replication |
| title_full | Identification of cepharanthine as an effective inhibitor of African swine fever virus replication |
| title_fullStr | Identification of cepharanthine as an effective inhibitor of African swine fever virus replication |
| title_full_unstemmed | Identification of cepharanthine as an effective inhibitor of African swine fever virus replication |
| title_short | Identification of cepharanthine as an effective inhibitor of African swine fever virus replication |
| title_sort | identification of cepharanthine as an effective inhibitor of african swine fever virus replication |
| topic | African swine fever virus cepharanthine cholesterol biosynthesis transcriptome analysis EHD2 |
| url | https://www.tandfonline.com/doi/10.1080/22221751.2024.2429624 |
| work_keys_str_mv | AT chuanxiangqi identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT jiyounglee identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT yongqiangzhang identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT huanchen identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT jiaxuanlv identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT zhenzhongwang identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT jinmingli identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT xiaodongwu identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT yongsamjung identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT zhiliangwang identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication AT yingjuanqian identificationofcepharanthineasaneffectiveinhibitorofafricanswinefevervirusreplication |